The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...
NEWS: Tagged in Locus unveils $80m Sorrento plan 14 Nov 2024 NEWS: Tagged in Locus’ $38m Freo townhouses approved 27 Mar 2024 NEWS: Tagged in Locus with $17m Hillarys play 25 Jan 2024 NEWS: Tagged in ...
Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Yarilet Perez is an experienced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback